Register or Login
  • All
  • Uniprot Id
  • Catalog #
  • Peptide Sequence
>   home   >   News & Announcements   >   Target of the Week - CD73 Antibodies   

Target of the Week - CD73 Antibodies

Jun 29, 2015

Dear Researcher,

Abgent offers a portfolio of antibodies for the the detection of CD73 (NT5E). Applications include western blotting, immunohistochemistry, and ELISA for human and mouse models.

CD73 (NT5E or Ecto-5-prime-nucleotidase) catalyzes the conversion at neutral pH of purine 5-prime mononucleotides to nucleosides, with AMP the preferred substrate. CD73 on immune cells is emerging as an important pathway and therapeutic target in cardiovascular and autoimmune disorders.

To find the right CD73 antibody for your research, please visit Abgent CD73 Antibodies.

IHC for Cat# AO1908a Polyclonal CD73 Antibody WB for Cat# AM2223a Monoclonal CD73 Antibody IHC for Cat# AP2014A Polyclonal CD73 Antibody
Abgent is pleased to announced the new with fresh content, research tools, and 10,000+ original manufactured products organized by key areas of research including cancer, metabolism, cardiovascular, neuroscience, stem cells, immunology, and developmental biology.
Abgent is highlighted in the Antibody Quality Review published by Nature.